You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dasatinib

Showing 1 - 25 of 229
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dasatinib
  • (no location specified)
Sep 20, 2023

Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Dasatinib
  • Palo Alto, California
    Stanford University
Aug 14, 2023

Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Dasatinib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Dasatinib
  • Decitabine and Cedazuridine
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

Completed
  • Acute,Leukemia, Lymphoid
  • Dasatinib
  • +12 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 2, 2022

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Dasatinib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Dasatinib
  • +5 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

Recruiting
  • Chronic Myeloid Leukemia in Chronic Phase
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Jul 26, 2022

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Prostate Cancer Trial (Dasatinib)

Withdrawn
  • Prostate Cancer
  • Dasatinib
  • (no location specified)
Feb 23, 2022

Aging Trial in Boston (Dasatinib, Quercetin)

Recruiting
  • Aging
  • Boston, Massachusetts
    Hebrew Senior Life
Jun 13, 2022

Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)

Terminated
Has Results
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Dasatinib
  • +2 more
  • Chicago, Illinois
  • +1 more
Jun 2, 2022

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)

Completed
  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  • dasatinib
  • Valencia, Spain
    Hospital La Fe
Mar 16, 2022

Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Dasatinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2022

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Dasatinib
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)

Terminated
Has Results
  • Rhabdomyosarcoma
  • +2 more
  • Los Angeles, California
  • +1 more
Mar 17, 2022

Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

Recruiting
  • Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 28, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Dasatinib
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Multiple Indications Cancer Trial in France, Poland (Dasatinib)

Active, not recruiting
  • Multiple Indications Cancer
  • Dasatinib
  • Besancon, France
  • +5 more
Dec 2, 2021

Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)

Completed
Has Results
  • Breast Cancer
  • Bone Metastases
  • Dasatinib
  • Zoledronic Acid
  • Chicago, Illinois
  • +2 more
Feb 2, 2022

EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

Active, not recruiting
  • EGFR Gene Mutation
  • Nonsmall Cell Lung Cancer
  • Washington, District of Columbia
  • +1 more
Jan 9, 2022